Hamzeh is a statistical geneticist experienced in analysing genetic data to interpret genetic factors underlying common diseases. During his PhD, he analysed many thousands of genetic data to develop a computational framework that identifies intermediate molecules (metabolites and proteins) connecting the genome to disease endpoints. Hamzeh’s research at the Daffodil Centre focuses on the development, validation and evaluation of genetic risk tools for four major cancers in Australia (breast, colorectal, melanoma, and prostate) using genetic data from large datasets including international consortia, UK Biobank, and the 45 and Up Study. Hamzeh hopes that his research will improve cancer screening and early detection in Australia.
